3LW0 | pdb_00003lw0

IGF-1RK in complex with ligand MSC1609119A-1


Experimental Data Snapshot

  • Method:&nbspX-RAY DIFFRACTION
  • Resolution:&nbsp1.79 Å
  • R-Value Free:&nbsp
    0.185 (Depositor), 0.200 (DCC)&nbsp
  • R-Value Work:&nbsp
    0.157 (Depositor), 0.170 (DCC)&nbsp

Starting Model: experimental
View more details

wwPDB Validation&nbsp &nbsp3D Report&nbspFull Report


Ligand Structure Quality Assessment&nbsp


This is version 1.3 of the entry. See complete&nbsphistory.&nbsp


Literature

Allosteric IGF-1R Inhibitors.

Heinrich, T.,&nbspGradler, U.,&nbspBottcher, H.,&nbspBlaukat, A.,&nbspShutes, A.

(2010) ACS Med Chem Lett&nbsp1: 199-203

  • DOI:&nbsphttps://doi.org/10.1021/ml100044h
  • Primary Citation of Related Structures: &nbsp
    3LW0

  • PubMed Abstract:&nbsp

    Targeting allosteric protein sites is a promising approach to interfere selectively with cellular signaling cascades. We have discovered a novel class of allosteric insulin-like growth factor-I receptor (IGF-1R) inhibitors. 3-Cyano-1H-indole-7-carboxylic acid {1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl}amide (10) was found with nanomolar biochemical, micromolar, cellular IGF-1R activity and no relevant interference with cellular insulin receptor signaling up to 30 μM. The allosteric binding site was characterized by X-ray crystallographic studies, and the structural information was used to explain the unique mode of action of this new class of inhibitors.


  • Organizational Affiliation:&nbsp

    Merck Serono, Frankfurter Strasse 250, 64293 Darmstadt, Germany.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Insulin-like growth factor 1 receptor
A, B, C, D
304Homo sapiensMutation(s): 2&nbsp
Gene Names:&nbspIGF1R
EC:&nbsp2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for&nbspP08069&nbsp(Homo sapiens)
Explore&nbspP08069&nbsp
Go to UniProtKB: &nbspP08069
PHAROS: &nbspP08069
GTEx: &nbspENSG00000140443&nbsp
Entity Groups &nbsp
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08069
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands&nbsp2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
CCX
Query on CCX

Download Ideal Coordinates CCD File&nbsp
E [auth A]
F [auth A]
G [auth B]
H [auth B]
J [auth C]
E [auth A],
F [auth A],
G [auth B],
H [auth B],
J [auth C],
K [auth C],
M [auth D],
N [auth D]
3-cyano-N-{1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl}-1H-indole-7-carboxamide
C28 H28 N6 O
GVZDPXYOJHKYRC-UHFFFAOYSA-N
GOL
Query on GOL

Download Ideal Coordinates CCD File&nbsp
I [auth B],
L [auth C]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method:&nbspX-RAY DIFFRACTION
  • Resolution:&nbsp1.79 Å
  • R-Value Free:&nbsp 0.185 (Depositor), 0.200 (DCC)&nbsp
  • R-Value Work:&nbsp 0.157 (Depositor), 0.170 (DCC)&nbsp
Space Group:&nbspH 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 189.346α = 90
b = 189.346β = 90
c = 115.92γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View&nbspFull Validation Report



Ligand Structure Quality Assessment&nbsp


Entry History&nbsp

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2010-09-29
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2019-12-25
    Changes: Advisory, Database references
  • Version 1.3: 2023-11-01
    Changes: Advisory, Data collection, Database references, Derived calculations, Refinement description